Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hemochromatosis"" wg kryterium: Temat


Starter badań:

Tytuł:
Hemochromatosis: Ferroptosis, ROS, Gut Microbiome, and Clinical Challenges with Alcohol as Confounding Variable.
Autorzy:
Teschke R; Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, D-63450 Hanau, Germany.; Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/Main, D-60590 Frankfurt am Main, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 25; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hemochromatosis*/genetics
Alcoholism*/complications
Ferroptosis*
Gastrointestinal Microbiome*
Iron Overload*/genetics
Liver Neoplasms*/complications
Humans ; Hepcidins/metabolism ; Reactive Oxygen Species/metabolism ; Artificial Intelligence ; Confounding Factors, Epidemiologic ; Histocompatibility Antigens Class I/genetics ; Hemochromatosis Protein/metabolism ; Membrane Proteins/metabolism ; Iron/metabolism ; Ferritins ; Ethanol
Czasopismo naukowe
Tytuł:
Height of non-Hispanic white adults with homeostatic iron regulator HFE genotypes p.C282Y/p.C282Y and wt/wt.
Autorzy:
Barton JC; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Southern Iron Disorders Center, Birmingham, Alabama, USA.
Barton JC; Southern Iron Disorders Center, Birmingham, Alabama, USA.
Acton RT; Southern Iron Disorders Center, Birmingham, Alabama, USA.; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2024 Jan; Vol. 12 (1), pp. e2321. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article
MeSH Terms:
Body Height*/ethnology
Body Height*/genetics
Hemochromatosis*/diagnosis
Hemochromatosis*/ethnology
Hemochromatosis*/genetics
White People*/genetics
Adult ; Female ; Humans ; Male ; Ferritins ; Genotype ; Hemochromatosis Protein/genetics ; Histocompatibility Antigens Class I/genetics ; Iron
Czasopismo naukowe
Tytuł:
Platelet counts in HFE p.C282Y/p.C282Y and wt/wt post-screening clinical evaluation participants.
Autorzy:
Barton JC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Southern Iron Disorders Center, Birmingham, AL, USA.
Barton JC; Southern Iron Disorders Center, Birmingham, AL, USA.
Acton RT; Southern Iron Disorders Center, Birmingham, AL, USA.; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Pokaż więcej
Źródło:
Platelets [Platelets] 2023 Dec; Vol. 34 (1), pp. 2217933.
Typ publikacji:
Journal Article
MeSH Terms:
Hemochromatosis*/complications
Hemochromatosis*/diagnosis
Hemochromatosis*/genetics
Male ; Humans ; Female ; Middle Aged ; C-Reactive Protein ; Platelet Count ; Histocompatibility Antigens Class I/genetics ; Hemochromatosis Protein/genetics ; Ferritins/genetics ; Genotype ; Hemoglobins/genetics ; Mutation ; Homozygote
Czasopismo naukowe
Tytuł:
Hfe Actions in Kupffer Cells Are Dispensable for Hepatic and Systemic Iron Metabolism.
Autorzy:
Knoop P; Institute of Comparative Molecular Endocrinology, Ulm University, 89081 Ulm, Germany.
Yilmaz D; Institute of Comparative Molecular Endocrinology, Ulm University, 89081 Ulm, Germany.
Paganoni R; Institute of Comparative Molecular Endocrinology, Ulm University, 89081 Ulm, Germany.
Steele-Perkins P; Institute of Comparative Molecular Endocrinology, Ulm University, 89081 Ulm, Germany.
Gruber A; Institute of Analytical and Bioanalytical Chemistry, Ulm University, 89081 Ulm, Germany.
Akdogan B; Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, 85764 Neuherberg, Germany.
Zischka H; Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, 85764 Neuherberg, Germany.; Institute of Toxicology and Environmental Hygiene, Technical University Munich, School of Medicine, 80802 Munich, Germany.
Leopold K; Institute of Analytical and Bioanalytical Chemistry, Ulm University, 89081 Ulm, Germany.
Vujić Spasić M; Institute of Comparative Molecular Endocrinology, Ulm University, 89081 Ulm, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 18; Vol. 24 (10). Date of Electronic Publication: 2023 May 18.
Typ publikacji:
Journal Article
MeSH Terms:
Kupffer Cells*/metabolism
Hemochromatosis*/genetics
Hemochromatosis*/metabolism
Mice ; Animals ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/metabolism ; Hemochromatosis Protein/genetics ; Hemochromatosis Protein/metabolism ; Membrane Proteins/metabolism ; Liver/metabolism ; Hepcidins/genetics ; Hepcidins/metabolism ; Iron/metabolism ; Mice, Knockout
Czasopismo naukowe
Tytuł:
The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis.
Autorzy:
Olynyk JK; Medical School, Curtin University, Bentley, WA, Australia. .; Department of Gastroenterology, Fiona Stanley Fremantle Hospital Group, Murdoch, WA, Australia. .
Grainger R; Department of Gastroenterology, Fiona Stanley Fremantle Hospital Group, Murdoch, WA, Australia.
Currie H; Department of Gastroenterology, Fiona Stanley Fremantle Hospital Group, Murdoch, WA, Australia.
Ramm LE; QIMR-Berghofer Medical Research Institute, Herston, QLD, Australia.; Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
Ramm GA; QIMR-Berghofer Medical Research Institute, Herston, QLD, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 13; Vol. 13 (1), pp. 7775. Date of Electronic Publication: 2023 May 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hemochromatosis*/genetics
Hemochromatosis*/pathology
Humans ; HLA-A3 Antigen/genetics ; Haplotypes ; Histocompatibility Antigens Class I/genetics ; HLA-B7 Antigen/genetics ; Hemochromatosis Protein/genetics ; Liver Cirrhosis/genetics ; Liver Cirrhosis/pathology ; Iron ; Homozygote ; HLA Antigens/genetics
Czasopismo naukowe
Tytuł:
The Influence of Hemochromatosis Gene (HFE) Mutations on SARS-CoV-2 Susceptibility and COVID-19 Severity
Autorzy:
Ristić S; Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Milić S; Department of Gastroenterology, Clinical Hospital Centre Rijeka, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Tatalović T; Department of Rheumatology and Clinical Immunology, Clinical Hospital Centre Rijeka, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Bilobrk M; Department of Epidemiology, Teaching Institute of Public Health of Primorje-Gorski Kotar County, Faculty of Health Studies, University of Rijeka, Rijeka, Croatia
Rončević D; Department of Epidemiology, Teaching Institute of Public Health of Primorje-Gorski Kotar County, Faculty of Health Studies, University of Rijeka, Rijeka, Croatia
Ćurko-Cofek B; Department of Physiology, Immunology and Pathophysiology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Barac-Latas V; Department of Physiology, Immunology and Pathophysiology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Čizmarević NS; Department of Medical Biology and Genetics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Pokaż więcej
Źródło:
Balkan medical journal [Balkan Med J] 2023 May 08; Vol. 40 (3), pp. 229-231. Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:
Research Support, Non-U.S. Gov't; Letter
MeSH Terms:
COVID-19*/genetics
Hemochromatosis*/genetics
Biochemical Phenomena*
Humans ; SARS-CoV-2/genetics ; Mutation ; Hemochromatosis Protein/genetics
Raport
Tytuł:
Cardiac Hamp mRNA Is Predominantly Expressed in the Right Atrium and Does Not Respond to Iron.
Autorzy:
Bigorra Mir M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Charlebois E; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Tsyplenkova S; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Fillebeen C; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Pantopoulos K; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 08; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Iron*/metabolism
Hemochromatosis*/genetics
Hemochromatosis*/metabolism
Mice ; Animals ; Hepcidins/genetics ; Hepcidins/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Hemochromatosis Protein/genetics ; Hemochromatosis Protein/metabolism ; Liver/metabolism ; Heart Atria/metabolism ; GPI-Linked Proteins/genetics ; GPI-Linked Proteins/metabolism
Czasopismo naukowe
Tytuł:
Protein Susceptibility to Peroxidation by 4-Hydroxynonenal in Hereditary Hemochromatosis.
Autorzy:
Sánchez-Jaut S; Department of Biochemistry and Molecular Biology, Complutense University of Madrid, 28040 Madrid, Spain.; Research Institute Hospital 12 de Octubre, 28041 Madrid, Spain.
Pérez-Benavente S; Department of Biochemistry and Molecular Biology, Complutense University of Madrid, 28040 Madrid, Spain.; Research Institute Hospital 12 de Octubre, 28041 Madrid, Spain.
Abad P; Department of Biochemistry and Molecular Biology, Complutense University of Madrid, 28040 Madrid, Spain.; Research Institute Hospital 12 de Octubre, 28041 Madrid, Spain.
Méndez-Cuadro D; Analytical Chemistry and Biomedicine Group, School of Exact and Natural Sciences, San Pablo Campus, University of Cartagena, Cartagena 130014, Colombia.
Puyet A; Department of Biochemistry and Molecular Biology, Complutense University of Madrid, 28040 Madrid, Spain.; Research Institute Hospital 12 de Octubre, 28041 Madrid, Spain.
Diez A; Department of Biochemistry and Molecular Biology, Complutense University of Madrid, 28040 Madrid, Spain.; Research Institute Hospital 12 de Octubre, 28041 Madrid, Spain.
Galicia-Poblet G; Pediatric Digestive Service, Guadalajara University Hospital, 19002 Guadalajara, Spain.
Gómez-Domínguez E; Research Institute Hospital 12 de Octubre, 28041 Madrid, Spain.
Moran-Jiménez MJ; Research Institute Hospital 12 de Octubre, 28041 Madrid, Spain.
Bautista JM; Department of Biochemistry and Molecular Biology, Complutense University of Madrid, 28040 Madrid, Spain.; Research Institute Hospital 12 de Octubre, 28041 Madrid, Spain.
Azcárate IG; Department of Medical Specialties and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 02; Vol. 24 (3). Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Journal Article
MeSH Terms:
Hemochromatosis*/genetics
Iron Overload*
Humans ; Male ; Mice ; Female ; Animals ; Aldehydes/metabolism ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Lipid Peroxidation ; Hemochromatosis Protein/genetics ; Hemochromatosis Protein/metabolism
Czasopismo naukowe
Tytuł:
Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.
Autorzy:
Barton JC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. .; Southern Iron Disorders Center, Birmingham, AL, USA. .
Barton JC; Southern Iron Disorders Center, Birmingham, AL, USA.
Acton RT; Southern Iron Disorders Center, Birmingham, AL, USA.; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Apr 28; Vol. 23 (1), pp. 137. Date of Electronic Publication: 2023 Apr 28.
Typ publikacji:
Journal Article
MeSH Terms:
Hemochromatosis*/complications
Hemochromatosis*/epidemiology
Hemochromatosis*/genetics
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/epidemiology
Iron Overload*/complications
Iron Overload*/epidemiology
Adult ; Male ; Humans ; Female ; Middle Aged ; Retrospective Studies ; Histocompatibility Antigens Class I/genetics ; Hemochromatosis Protein/genetics ; Iron ; Homozygote
Czasopismo naukowe
Tytuł:
Low-temperature Mössbauer spectroscopy of organs from hemochromatosis mice: an iron-dependent threshold for generating hemosiderin.
Autorzy:
Vali SW; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, USA.
Lindahl PA; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, USA. .; Department of Chemistry, Texas A&M University, College Station, TX, 77843-3255, USA. .
Pokaż więcej
Źródło:
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry [J Biol Inorg Chem] 2023 Mar; Vol. 28 (2), pp. 173-185. Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hemochromatosis*/genetics
Hemochromatosis*/complications
Iron Overload*/genetics
Mice ; Animals ; Iron/metabolism ; Hemosiderin ; Spectroscopy, Mossbauer ; Temperature ; Ferritins ; Ferrous Compounds ; Hemochromatosis Protein/genetics
Czasopismo naukowe
Tytuł:
Genetic Iron Overload Hampers Development of Cutaneous Leishmaniasis in Mice.
Autorzy:
Charlebois E; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Li Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Wagner V; Faculty of Veterinary Medicine, Université de Montréal, Montreal, QC J2S 2M2, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
Pantopoulos K; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.
Olivier M; Department of Medicine, McGill University, Montreal, QC H4A 3J1, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 14; Vol. 24 (2). Date of Electronic Publication: 2023 Jan 14.
Typ publikacji:
Journal Article
MeSH Terms:
Hemochromatosis*/genetics
Hemochromatosis*/metabolism
Leishmaniasis, Cutaneous*/genetics
Leishmaniasis, Cutaneous*/metabolism
Animals ; Mice ; GPI-Linked Proteins/metabolism ; Hemochromatosis Protein/genetics ; Hemochromatosis Protein/metabolism ; Hepcidins/genetics ; Hepcidins/metabolism ; Iron/metabolism ; Iron Overload/genetics ; Iron Overload/metabolism ; Liver/metabolism
Czasopismo naukowe
Tytuł:
Patient-reported outcomes and their relation with iron parameters in HFE haemochromatosis during maintenance therapy: A prospective cohort study.
Autorzy:
Belhomme N; Service de Médecine Interne et Immunologie Clinique, CHU de Rennes, Rennes, France.; Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France.; Unité d'Investigation Clinique, CHU de Rennes, Rennes, France.
Morcet J; Unité d'Investigation Clinique, CHU de Rennes, Rennes, France.
Lescoat A; Service de Médecine Interne et Immunologie Clinique, CHU de Rennes, Rennes, France.; Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Rennes, France.; Faculté de médecine, Université Rennes 1, Rennes, France.
Robin F; Faculté de médecine, Université Rennes 1, Rennes, France.; Service de Rhumatologie, CHU de Rennes, Rennes, France.; INSERM UMR 991, Rennes, France.
Deugnier Y; Unité d'Investigation Clinique, CHU de Rennes, Rennes, France.; Centre de référence des surcharges génétiques en fer, service des maladies du foie, CHU de Rennes, France.
Bardou-Jacquet E; Unité d'Investigation Clinique, CHU de Rennes, Rennes, France.; Faculté de médecine, Université Rennes 1, Rennes, France.; Centre de référence des surcharges génétiques en fer, service des maladies du foie, CHU de Rennes, France.
Lainé F; Unité d'Investigation Clinique, CHU de Rennes, Rennes, France.; Centre de référence des surcharges génétiques en fer, service des maladies du foie, CHU de Rennes, France.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Nov; Vol. 42 (11), pp. 2473-2481. Date of Electronic Publication: 2022 Jun 30.
Typ publikacji:
Journal Article
MeSH Terms:
Hemochromatosis*/complications
Hemochromatosis*/genetics
Hemochromatosis*/therapy
Arthralgia ; Fatigue/etiology ; Female ; Ferritins ; Hemochromatosis Protein/genetics ; Histocompatibility Antigens Class I ; Humans ; Iron/metabolism ; Patient Reported Outcome Measures ; Prospective Studies ; Quality of Life ; Transferrin
Czasopismo naukowe
Tytuł:
Engineering Peptide Inhibitors of the HFE-Transferrin Receptor 1 Complex.
Autorzy:
Goncalves Monteiro D; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Rishi G; Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia.
Gorman DM; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Burnet G; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Aliyanto R; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Rosengren KJ; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Frazer DM; The QIMR Berghofer Medical Research Institute, 300 Herston Rd, Brisbane, QLD 4006, Australia.
Subramaniam VN; Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia.
Clark RJ; School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Oct 04; Vol. 27 (19). Date of Electronic Publication: 2022 Oct 04.
Typ publikacji:
Journal Article
MeSH Terms:
Hemochromatosis*/genetics
Hemochromatosis*/metabolism
Hepcidins*/metabolism
Hemochromatosis Protein/genetics ; Hemochromatosis Protein/metabolism ; Histocompatibility Antigens Class I/genetics ; Histocompatibility Antigens Class I/metabolism ; Humans ; Iron/metabolism ; Lactams ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Peptides/metabolism ; Peptides/pharmacology ; Receptors, Transferrin/metabolism ; Transferrin/metabolism
Czasopismo naukowe
Tytuł:
The effect of a natural polyphenol supplement on iron absorption in adults with hereditary hemochromatosis.
Autorzy:
Buerkli S; Laboratory of Human Nutrition, Institute of Food Nutrition and Health, Department of Health Science and Technology, Swiss Federal Institute of Technology (ETH Zurich), LFV D27.2, Schmelzbergstrasse 7, CH8092, Zurich, Switzerland. .
Salvioni L; Laboratory of Human Nutrition, Institute of Food Nutrition and Health, Department of Health Science and Technology, Swiss Federal Institute of Technology (ETH Zurich), LFV D27.2, Schmelzbergstrasse 7, CH8092, Zurich, Switzerland.
Koller N; Laboratory of Human Nutrition, Institute of Food Nutrition and Health, Department of Health Science and Technology, Swiss Federal Institute of Technology (ETH Zurich), LFV D27.2, Schmelzbergstrasse 7, CH8092, Zurich, Switzerland.
Zeder C; Laboratory of Human Nutrition, Institute of Food Nutrition and Health, Department of Health Science and Technology, Swiss Federal Institute of Technology (ETH Zurich), LFV D27.2, Schmelzbergstrasse 7, CH8092, Zurich, Switzerland.
Teles MJ; Clinical Pathology, S. João University Hospital Center, Porto, Portugal.
Porto G; Clinical Hematology, Santo António Hospital, Porto University Hospital Center (CHUP), Porto, Portugal.; Abel Salazar Institute for Biomedical Sciences (ICBAS), Porto, Portugal.; Institute of Research and Innovation in Health Sciences (i3S) of the University of Porto, Porto, Portugal.
Habermann JH; Division of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Dubach IL; Division of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Vallelian F; Division of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland.
Frey BM; Blood Transfusion Service, Swiss Red Cross, Schlieren, Switzerland.
Moretti D; Laboratory of Human Nutrition, Institute of Food Nutrition and Health, Department of Health Science and Technology, Swiss Federal Institute of Technology (ETH Zurich), LFV D27.2, Schmelzbergstrasse 7, CH8092, Zurich, Switzerland.; Department of Health, Swiss Distance University of Applied Sciences, Regensdorf/Zurich, Switzerland.
Baumgartner J; Laboratory of Human Nutrition, Institute of Food Nutrition and Health, Department of Health Science and Technology, Swiss Federal Institute of Technology (ETH Zurich), LFV D27.2, Schmelzbergstrasse 7, CH8092, Zurich, Switzerland.
Zimmermann MB; Laboratory of Human Nutrition, Institute of Food Nutrition and Health, Department of Health Science and Technology, Swiss Federal Institute of Technology (ETH Zurich), LFV D27.2, Schmelzbergstrasse 7, CH8092, Zurich, Switzerland.
Pokaż więcej
Źródło:
European journal of nutrition [Eur J Nutr] 2022 Sep; Vol. 61 (6), pp. 2967-2977. Date of Electronic Publication: 2022 Mar 23.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Hemochromatosis*/drug therapy
Hemochromatosis*/genetics
Hemochromatosis*/metabolism
Adult ; Cross-Over Studies ; Hemochromatosis Protein ; Histocompatibility Antigens Class I/genetics ; Humans ; Iron ; Iron, Dietary ; Polyphenols/pharmacology ; Powders ; Single-Blind Method ; Tea
Czasopismo naukowe
Tytuł:
Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis.
Autorzy:
Zhang W; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.
Li Y; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.; Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Xu A; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.; Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Ouyang Q; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.; Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Wu L; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.
Zhou D; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.; Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Wu L; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.
Zhang B; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.; Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
Zhao X; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.
Wang Y; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.
Wang X; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.
Duan W; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.
Wang Q; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.
You H; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China.
Huang J; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China. .; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China. .; Experimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China. .
Ou X; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China. .; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China. .
Jia J; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, 95 Yong-An Road, Beijing, 100050, China. jia_.; National Clinical Research Center for Digestive Diseases, Beijing, 100050, China. jia_.
Pokaż więcej
Corporate Authors:
China Registry of Genetic/Metabolic Liver Diseases (CR-GMLD) Group
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2022 Jun 06; Vol. 17 (1), pp. 216. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hemochromatosis*/genetics
Iron Overload*/genetics
China ; Hemochromatosis Protein/genetics ; Histocompatibility Antigens Class I/genetics ; Humans ; Membrane Proteins/genetics ; Mutation/genetics ; Subtilisins/genetics ; Ubiquitin-Conjugating Enzymes/genetics
Czasopismo naukowe
Tytuł:
Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p.C282Y/p.C282Y.
Autorzy:
Barton JC; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.; Southern Iron Disorders Center, Birmingham, Alabama, United States of America.
Barton JC; Southern Iron Disorders Center, Birmingham, Alabama, United States of America.
Acton RT; Southern Iron Disorders Center, Birmingham, Alabama, United States of America.; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jul 27; Vol. 17 (7), pp. e0271973. Date of Electronic Publication: 2022 Jul 27 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Hemochromatosis*/complications
Iron Overload*/diagnosis
Adult ; Aged ; Female ; Ferritins ; Genotype ; Hemochromatosis Protein/genetics ; Humans ; Male ; Middle Aged ; Phenotype ; Transferrin/genetics
Czasopismo naukowe
Tytuł:
HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity.
Autorzy:
Barton JC; Southern Iron Disorders Center, Birmingham, AL, USA. .; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. .
Barton JC; Southern Iron Disorders Center, Birmingham, AL, USA.
Acton RT; Southern Iron Disorders Center, Birmingham, AL, USA.; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Pokaż więcej
Źródło:
Hereditas [Hereditas] 2022 Jun 06; Vol. 159 (1), pp. 25. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/complications
Hemochromatosis*/genetics
Iron Overload*/complications
Iron Overload*/genetics
Female ; HLA-A Antigens/genetics ; Haplotypes ; Hemochromatosis Protein/genetics ; Histocompatibility Antigens Class I/genetics ; Homozygote ; Humans ; Membrane Proteins/genetics ; Phenotype
Czasopismo naukowe
Tytuł:
Haemochromatosis patients' research priorities: Towards an improved quality of life.
Autorzy:
Romero-Cortadellas L; Department of Basic Sciences, Iron metabolism: Regulation and Diseases, Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, Barcelona, Spain.
Venturi V; Department of Basic Sciences, Iron metabolism: Regulation and Diseases, Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, Barcelona, Spain.
Martín-Sánchez JC; Group of Evaluation of Health Determinants and Health Policies, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Spain.
Toska K; Norwegian Haemochromatosis Association, Bergen, Norway.
Prince D; Haemochromatosis Australia, Meridan Plains, Queensland, Australia.
Butzeck B; Hämochromatose-Vereinigung Deutschland e.V. HVD, European Federation of Associations of Patients with Haemochromatosis (EFAPH), Hattingen, Germany.
Porto G; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; ICBAS-Instituto de Ciências Biomédicas Abel Salazar., Universidade do Porto, Porto, Portugal.
Milman NT; Danish Hemochromatosis Association, Copenhagen, Denmark.
Committee HS; EFAPH-European Federation of Associations of Patients with Haemochromatosis, Croissy-sur-Seine, France.
Sánchez M; Department of Basic Sciences, Iron metabolism: Regulation and Diseases, Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, Barcelona, Spain.; BloodGenetics S.L. Diagnostics in Inherited Blood Diseases, Esplugues de Llobregat, Spain.
Pokaż więcej
Źródło:
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2023 Dec; Vol. 26 (6), pp. 2293-2301. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Quality of Life*/psychology
Hemochromatosis*/genetics
Hemochromatosis*/therapy
Humans ; Surveys and Questionnaires ; Research
Czasopismo naukowe
Tytuł:
Prevalence of HFE-related haemochromatosis and secondary causes of hyperferritinaemia and their association with iron overload in 1059 French patients treated by venesection.
Autorzy:
Le Gac G; Brest, France.; Paris, France.
Scotet V; Brest, France.
Gourlaouen I; Brest, France.; Paris, France.
L'Hostis C; Brest, France.
Merour MC; Brest, France.
Karim Z; Paris, France.
Deugnier Y; Rennes, France.
Bardou-Jacquet E; Rennes, France.
Lefebvre T; Paris, France.
Assari S; La Plaine Saint-Denis, France.
Ferec C; Brest, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Apr; Vol. 55 (8), pp. 1016-1027. Date of Electronic Publication: 2022 Feb 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hemochromatosis*/epidemiology
Hemochromatosis*/genetics
Hyperferritinemia*
Iron Overload*/epidemiology
Iron Overload*/genetics
Adult ; Hemochromatosis Protein/genetics ; Humans ; Phlebotomy ; Prevalence
Czasopismo naukowe
Tytuł:
Factors associated with serum ferritin levels and iron excess: results from the EPIC-EurGast study.
Autorzy:
Iglesias-Vázquez L; Research group of Nutrition and Mental Health (NUTRISAM), Unit of Nutrition and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), Tarragona, Spain.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
Arija V; Research group of Nutrition and Mental Health (NUTRISAM), Unit of Nutrition and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), Tarragona, Spain. .; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. .; Institut d'investigació en Atenció Primària (IDIAP) Jordi Gol, Institut Català de la Salut (ICS), Barcelona, Spain. .
Aranda N; Research group of Nutrition and Mental Health (NUTRISAM), Unit of Nutrition and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), Tarragona, Spain.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
Aglago EK; International Agency for Research on Cancer (IARC), Lyon, France.
Cross AJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Schulze MB; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
Quintana Pacheco D; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kühn T; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Weiderpass E; International Agency for Research on Cancer (IARC), Lyon, France.
Tumino R; Cancer Registry and Histopathology Department, Provincial Health Authority (ASP 7) Ragusa, Ragusa, Italy.
Redondo-Sánchez D; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
de Magistris MS; Azienda Ospedialiera Universitaria (A.O.U.) Federico II, Naples, Italy.
Palli D; Cancer Risk Factors and Life-Style Epidemiology Unit Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Villa delle Rose, Florence, Italy.
Ardanaz E; Navarra Public Health Institute, Pamplona, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Laouali N; Paris-Saclay University, UVSQ, University Paris-Sud, Inserm, Gustave Roussy, 'Exposome and Heredity' Team, CESP, 94805, Villejuif, France.
Sonestedt E; Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Drake I; Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Rizzolo L; Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute -(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Santiuste C; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Sacerdote C; Unit of Cancer Epidemiology, Città Della Salute e Della Scienza University-Hospital, Via Santena 7, 10126, Turin, Italy.
Quirós R; EPIC Asturias, Public Health Directorate, Asturias, Spain.
Amiano P; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Public Health Division of Gipuzkoa, BioDonostia Research Institute, Donostia-San Sebastian, Spain.
Agudo A; Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute -(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Jakszyn P; Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute -(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. .; Blanquerna School of Health Sciences, Ramon Llull University, Barcelona, Spain. .
Pokaż więcej
Źródło:
European journal of nutrition [Eur J Nutr] 2022 Feb; Vol. 61 (1), pp. 101-114. Date of Electronic Publication: 2021 Jul 02.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*
Hemochromatosis*/epidemiology
Hemochromatosis*/genetics
Iron Overload*
Case-Control Studies ; Female ; Ferritins ; Hemochromatosis Protein/genetics ; Histocompatibility Antigens Class I ; Humans ; Iron ; Male ; Middle Aged
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies